Rewriting traumatic panic memories: a new therapy on trial

NCT ID NCT07769996

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This trial tests whether a 6-session therapy called Imagery Rescripting (ImRs) can reduce panic disorder symptoms by changing how people recall and process traumatic panic attack memories. Adults diagnosed with panic disorder are randomly assigned to receive the therapy or be in a control group. Researchers measure changes in symptom severity and physical arousal (heart rate and skin conductance) during memory recall, right after treatment and one month later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Imagery Rescripting (ImRs), a psychological therapy that helps people change the emotional impact of distressing memories
What this could lead to
If effective, this therapy could offer a new, drug-free way to reduce panic symptoms by targeting the traumatic memories that fuel them.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. The therapy may not outperform the control, and benefits may not last beyond one month.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANIC DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bağcılar Eğitim ve Araştırma Hastanesi

    Istanbul, Bağcılar, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.